Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase 11 study - Hyams, D.; Chan, Arlene; de Oliveira, C.; Snyder, R.; Vinholes, J.; Audeh, M W.; Alencar, V.; Lombard, J.; Mookerjee, B.; Xu, J.; Brown, K.; Klein, P. (Springer Science + Business Media, 2013)